Special considerations in pediatric asthma

Current Opinion in Pharmacology

Volumn 10, Issue 3, 2010, Pages 272-275

  Quizon, Annabelle ^a   Colin, Andrew A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CHLOROFLUOROCARBON; CICLESONIDE; CORTICOSTEROID; FLUORINATED HYDROCARBON; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MOMETASONE FUROATE; MONTELUKAST; OMALIZUMAB; PLACEBO; SALBUTAMOL; THEOPHYLLINE; ZAFIRLUKAST; ZILEUTON; ANTIASTHMATIC AGENT; GLUCOCORTICOID;

ADRENAL SUPPRESSION; ASTHMA; CLINICAL TRIAL; DISEASE CONTROL; DISEASE SEVERITY; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; DRUG USE; EARLY INTERVENTION; GROWTH RATE; GROWTH RETARDATION; HEPATITIS; HIGH RISK PATIENT; HUMAN; HYPERBILIRUBINEMIA; METERED DOSE INHALER; MILD PERSISTENT ASTHMA; OBESITY; PEDIATRICS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; WHEEZING; AGE; CHILD; DOSE RESPONSE; INHALATIONAL DRUG ADMINISTRATION; NATIONAL HEALTH ORGANIZATION; PATHOPHYSIOLOGY; UNITED STATES;

ADMINISTRATION, INHALATION; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 77954659021     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2010.04.012     Document Type: Review

References (34)

1. Yunginger J.W., Reed C.E., O'Connell E.J., Melton L.J., O'Fallon W.M., Silverstein M.D. A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis 1992, 146:888-894.
2. Sears M.R., Greene J.M., Willan A.R., Wiecek E.M., Taylor R., Flannery E.M., Cowan J.O., Herbison G.P., Silva P.A., Poulton R. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003, 349:1414-1422.
3. Phelan P.D., Robertson C.F., Olinsky A. The Melbourne Asthma Study: 1964-1999. J Allergy Clin Immunol 2002, 109:189-194.
4. Morgan W.J., Stern D.A., Sherrill D.L., Guerra S., Holberg C.J., Guilbert T.W., Taussig L.M., Wright A.L., Martinez F.D. Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. Am J Respir Crit Care Med 2005, 172:1253-1258.
5. Stern D.A., Morgan W.J., Wright A.L., Guerra S., Martinez F.D. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 2007, 370:758-764.
6. Guilbert T.W., Morgan W.J., Zeiger R.S., Mauger D.T., Boehmer S.J., Szefler S.J., Bacharier L.B., Lemanske R.F., Strunk R.C., Allen D.B., et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006, 354:1985-1997.
7. Bisgaard H., Hermansen M.N., Loland L., Halkjaer L.B., Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 2006, 354:1998-2005.
8. Bacharier L.B., Phillips B.R., Zeiger R.S., Martinez F.D., Lemanske R.F., Sorkness C.A., Bloomberg G.R., Morgan W., Pauli E. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol 2008, 122. 1127-1135 e8.
9. Murray C.S., Woodcock A., Langley S.J., Morris J., Custovic A. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. Lancet 2006, 368:754-762.
10. Gotzsche P.C., Johansen H.K., Schmidt L.M., Burr M.L. House dust mite control measures for asthma. Cochrane Database Syst Rev 2004, CD001187.
11. Arshad S.H., Bateman B., Sadeghnejad A., Gant C., Matthews S.M. Prevention of allergic disease during childhood by allergen avoidance: the Isle of Wight prevention study. J Allergy Clin Immunol 2007, 119:307-313.
12. Chan-Yeung M., Ferguson A., Watson W., Dimich-Ward H., Rousseau R., Lilley M., DyBuncio A., Becker A. The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age. J Allergy Clin Immunol 2005, 116:49-55.
13. Rayens M.K., Burkhart P.V., Zhang M., Lee S., Moser D., Mannino D., Hahn E. Reduction in asthma-related emergency department visits after implementation of a smoke-free law. J Allergy Clin Immunol 2008, 122. 537-541 e3.
14. DiFranza J.R., Aligne C.A., Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics 2004, 113(4 Suppl.):1007-1015.
15. Renzetti G., Silvestre G., D'Amario C., Bottini E., Gloria-Bottini F., Bottini N., Auais A., Perez M.K., Piedemonte G. Less air pollution leads to rapid reduction of airway inflammation and improved airway function in asthmatic children. Pediatrics 2009, 123:1051-1058.
16. Kramer M.S., Matush L., Vanilovich I., Platt R., Bogdanovich N., Sevkovskaya Z., Dzikovich I., Shisuko G., Mazar B. Effect of prolonged and exclusive breast feeding on risk of allergy and asthma: cluster randomised trial. BMJ 2007, 335:815.
17. Taveras E.M., Rifas-Shiman S.L., Camargo C.A., Gold D., Litonjua A., Oken E., Weiss S., Gillman M. Higher adiposity in infancy associated with recurrent wheeze in a prospective cohort of children. J Allergy Clin Immunol 2008, 121. 1161-1166 e3.
18. Litonjua A.A., Gold D.R. Asthma and obesity: common early-life influences in the inception of disease. J Allergy Clin Immunol 2008, 121:1075-1084. quiz 85-86.
19. Shore S.A. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol 2008, 121:1087-1093. quiz 94-95.
20. National Heart, Lung, and Blood Institute National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma 2007, National Institutes of Health, Bethesda, MD.
21. Skoner D.P. Balancing safety and efficacy in pediatric asthma management. Pediatrics 2002, 109(2 Suppl.):381-392.
22. Sharek P.J., Bergman D.A. The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis. Pediatrics 2000, 106:E8.
23. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000, 343:1054-1063. The Childhood Asthma Management Program Research Group.
24. Anthracopoulos M.B., Papadimitriou A., Panagiotakos D.B., Syridow G., Giannakopoulou E., Fretzayas A., Niclaidou P., Priftis K. Growth deceleration of children on inhaled corticosteroids is compensated for after the first 12 months of treatment. Pediatr Pulmonol 2007, 42:465-470.
25. Agertoft L., Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000, 343:1064-1069.
26. Leone F.T., Fish J.E., Szefler S.J., West S.L. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest 2003, 124:2329-2340.
27. Skoner D.P., Maspero J., Banerji D. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics 2008, 121:e1-14.
28. Adams N., Bestall J., Jones P.W. Budesonide at different doses for chronic asthma. Cochrane Database Syst Rev 2001, CD003271.
29. Eid N., Morton R., Olds B., Clark P., Sheikh S., Looney S. Decreased morning serum cortisol levels in children with asthma treated with inhaled fluticasone propionate. Pediatrics 2002, 109:217-221.
30. Bacharier L.B., Raissy H.H., Wilson L., McWilliams B., Strunk R.C., Kelly H.W. Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma. Pediatrics 2004, 113:1693-1699.
31. Kelly H.W., Van Natta M.L., Covar R.A., Tonascia J., Green R.P., Strunk R.C. Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study. Pediatrics 2008, 122:e53-e61.
32. Schlienger R.G., Jick S.S., Meier C.R. Inhaled corticosteroids and the risk of fractures in children and adolescents. Pediatrics 2004, 114:469-473.
33. Boushey H.A., Sorkness C.A., King T.S., Sullivan S.D., Fahy J.V., Lazarus S.C., Chinchilli V.M., Craig T.J., Dimango E.A., Deykin A., et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 2005, 352:1519-1528.
34. Turpeinen M., Nikander K., Pelkonen A.S., Syvanen P., Sorva R., Raitio H., Malmberg P., Juntunen-Backman K., Haahtela T. Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study). Arch Dis Child 2008, 93:654-659.